When cultured under hypoxic conditions, iPS cells and cancer cells change the expression levels of PFKFB3 and PFK-1 similarly in CSCs, supposing that CSCs might enhance glycolysis due to hypoxia-mediated modulation of restriction point (R-point) markers such as PFK-1 and PFKFB3. This evidence concerns the gene PFKM and cancer.